Cronos Group Inc vs MONDELEZ INTERNATIONAL INC Common Stock — how do they compare? Cronos Group Inc trades at $3.24 (market cap $1.18B), while MONDELEZ INTERNATIONAL INC Common Stock trades at $60.48 (market cap $77.43B). The key difference: MONDELEZ INTERNATIONAL INC Common Stock is far larger — about 65.6× Cronos Group Inc's market cap, and MONDELEZ INTERNATIONAL INC Common Stock pays a 3.43% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and MONDELEZ INTERNATIONAL INC Common Stock for 107 Days on average.
| CRON | MDLZ | |
|---|---|---|
Market Cap | $1.18B | $77.43B |
Volume | 968,037 | 7,695,104 |
Sector | Health | Consumer Staples |
52-Week High | $3.55 | $64.99 |
52-Week Low | $2.30 | $51.51 |
Typical Hold Time | 22 Days | 107 Days |
Enterprise Value | $387.62M | $97.78B |
Dividend Yield | — | 3.43% |
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.24, down 1.37% today amid a bearish technical signal. Recent quarterly earnings show beats in Q1 and Q2 2026, with revenue growth from $118M in 2024 to $147M in 2025. The company reported a net loss of $9.45M in 2025 but projects a profit of $70M for 2026. Analyst sentiment is mixed with a 20% buy rating. News highlights focus on international expansion and a recent Investor Day outlining growth strategies.
Outlook is cautiously optimistic given projected profitability in 2026 and strong cash reserves, but risks include sustained negative cash flow and competitive pressures. The stock's valuation metrics like P/E of 16.95 and P/S of 6.84 suggest moderate pricing relative to peers, though high EV/EBITDA of 43 indicates premium expectations.
Mondelez International (MDLZ) trades at $59.38, down 0.4% with a bearish technical signal despite beating earnings expectations for three consecutive quarters. The company maintains solid fundamentals with $38.54B revenue, 8.86% net margin, and strong analyst support (76% buy ratings). Recent developments include a dividend increase to $0.52 per share and new product launches like Toblerone Diamond Truffles.
MDLZ presents a compelling long-term opportunity with attractive valuation metrics (P/E 22.22) and 14% upside to consensus price target of $70.29. Key risks include cocoa cost pressures and competitive snack market dynamics, but the company's global brand strength and consistent execution support bullish outlook for patient investors.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →Mondelez has operated as an independent organization since its split from the former Kraft Foods North American grocery business in October 2012. The firm is a leading player in the global snack arena with a presence in the biscuit (47% of sales), chocolate (32%), gum/candy (10%), beverage (4%), and cheese and grocery (7%) aisles. Mondelez's portfolio includes well-known brands like Oreo, Chips Ahoy, Halls, Trident, and Cadbury, among others. The firm derives around one third of revenue from developing markets, nearly 40% from Europe, and the remainder from North America.
Read more on MDLZ →